GASTROOESOPHAGEAL JUNCTION CANCER

Clinical trials for GASTROOESOPHAGEAL JUNCTION CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTROOESOPHAGEAL JUNCTION CANCER trials appear

Sign up with your email to follow new studies for GASTROOESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Groundbreaking first human trial launches for new cancer fighter

Disease control Recruiting now

This is the first-ever study in humans of a new experimental drug called TH9619 for people with advanced solid tumors. The trial aims to find a safe and effective dose while checking how the body processes the drug and whether it shows signs of fighting cancer. It's open to adult…

Matched conditions: GASTROOESOPHAGEAL JUNCTION CANCER

Phase: PHASE1, PHASE2 • Sponsor: One-carbon Therapeutics AB • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

GASTROOESOPHAGEAL JUNCTION CANCER

Get alerted when new GASTROOESOPHAGEAL JUNCTION CANCER trials appear

Groundbreaking first human trial launches for new cancer fighter